Flow Cytometric Immune Monitoring of B. Afzelii-Specific T Lymphocytes
- Sponsor
- University Hospital, Strasbourg, France
- Study ID
- NCT07703787
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Lyme Borreliosis
- Lyme Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Study Details
Lyme borreliosis diagnosis currently relies on clinical assessment and detection of Borrelia-specific antibodies. However, serology does not allow reliable assessment of active infection. Evaluation of the cellular immune response through Borrelia-specific T lymphocyte monitoring may provide complementary diagnostic and prognostic information. This study aims to assess Borrelia afzelii-specific T-cell responses using multiparameter flow cytometry after stimulation with standardized peptide pools. This approach enables the characterization of CD4+ and CD8+ T cells, including polyfunctional immune responses. The diagnostic and prognostic value of this immunomonitoring strategy will be evaluated in patients with acrodermatitis chronica atrophicans, a late manifestation of Lyme borreliosis associated with B. afzelii.
Key Dates
- First listed
- Jul 14, 2026
- Start date
- Sep 30, 2026
- Status verified
- Jul 2026
- Primary completion
- Mar 31, 2029
- Completion
- Mar 31, 2029
Study Design
- Enrollment
- 20 participants (estimated)
Arms
- Arm: Lyme borreliosis / Acrodermatitis chronica atrophicans (ACA) group
- Arm: Control group
Primary Outcome Measure
Characterization of Borrelia afzelii-specific T-cell immune responses by multiparameter flow cytometry [ Time Frame: At study inclusion (baseline visit) ]
Central Contacts
- Sarah HUSTACHE+33 3 88 11 54 15
Related Studies
- A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Post Treatment Lyme Disease Syndrome and Selected Control PopulationsRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland
- Evaluation, Treatment, and Follow-up of Patients With Lyme DiseaseRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland
- Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordRecruiting · Sanford Health · Sioux Falls, South Dakota
- Rheumatology Patient Registry and BiorepositoryRecruiting · Yale University · New Haven, Connecticut